
Bart Roep, Ph.D., Has Type 1 Diabetes Cure in His Sights
Bart Roep, Ph.D., Has Type 1 Diabetes Cure in His Sights
Bart O. Roep, Ph.D., has dedicated his life to the search for a cure for type 1 diabetes. And he thinks he is on the brink.
Roep, an internationally renowned immunologist who joined City of Hope last year from the Netherlands Leiden University Medical Center, was recently named the Chan Soon-Shiong Shapiro Distinguished Chair in Diabetes. He believes that this endowment and a $50 million funding project led by the Wanek family will be key in stopping the disease.
We need to do something in addition to treating the symptoms, Roep said. Diabetes has surpassed cancer as a cause of death. One of the goals of the diabetes program at City of Hope is to accelerate the progress against the disease. And the new $50-million grant is a catalyst to get there faster.
Instead of dealing with the effects of the disease, Roep is committed to treating the disease itself.
For 100 years, weve known how to deal with the symptoms, he said. Now, for the first time, we can tackle the cause. This is really one of the most exciting times since the discovery of insulin. We have the opportunity to offer a completely new generation of therapy to these patients.
After studying the mechanism of type 1 diabetes for the last two decades, Roep, the founding chair of the DepartmentofDiabetesImmunology within the Diabetes&MetabolismResearchInstituteatCityofHope , recently had his Eureka! moment when he realized that the disorder varies greatly from patient to patient.
One of the new insights is that diabetes is very diverse, he said. Based on
Continue
reading